Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Trial details
- Registry ID
- NCT06848348
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic PainNCT06848348 | DWTX | Phase 2 | Active not recruiting | 2026-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |